7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 
      
    		                                               
      operating activities
    		                                               
      net income
    		15,287,000 17,881,000 26,842,000 -85,226,000 71,336,000 60,605,000 -49,162,000 52,866,000 42,410,000 18,905,000 48,649,000 64,374,000 42,959,000 30,711,000 39,069,000 77,232,000 121,306,000 27,551,000 51,444,000 44,904,000 180,685,000 55,445,000 73,217,000 92,189,000 71,329,000 23,493,000 73,802,000 104,811,000 81,973,000 100,636,000 76,549,000 19,769,000 60,616,000 140,568,000 72,139,000 178,675,000 58,095,000 50,356,000 71,557,000 60,995,000 52,253,000 32,061,000 72,029,000 65,808,000 64,887,000 66,632,000 101,980,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                               
      net income from discontinued operations, net of tax
    		                                               
      depreciation and amortization
    		30,477,000 29,551,000 29,253,000 29,539,000 29,288,000 30,430,000 32,777,000 32,779,000 33,016,000 33,225,000 32,191,000 34,486,000 33,891,000 33,343,000 32,559,000 31,720,000 31,485,000 31,294,000 29,737,000 29,353,000 30,678,000 38,189,000 39,743,000 37,316,000 37,579,000 34,212,000 36,225,000 35,582,000 34,145,000 32,761,000 32,466,000 31,127,000 30,405,000 29,453,000 29,182,000 25,349,000 23,227,000 22,924,000 21,850,000 21,470,000 17,912,000 14,617,000 14,091,000 14,403,000 11,211,000 10,713,000 10,198,000 
      equity in net income (income) of unconsolidated affiliates
    		3,358,000     -1,344,000 -753,000 666,000 1,726,000                                       
      deferred income taxes
    		5,407,000 8,062,000 12,950,000 -18,890,000 24,954,000 29,539,000 2,821,000 -11,498,000 -143,435,000 69,320,000 124,000 -197,000 2,156,000 19,866,000 17,036,000 1,190,000 18,700,000 39,615,000 4,228,000 2,008,000 -129,543,000 7,586,000 7,026,000 55,353,000 -1,985,000 4,131,000 5,104,000 -1,945,000 4,588,000 -10,560,000 7,902,000 227,350,000 8,298,000 -52,107,000 -3,545,000 99,140,000 17,074,000 3,369,000 1,014,000 8,134,000 13,197,000       
      stock-based compensation
    		8,165,000 7,564,000 6,071,000 2,588,000 6,931,000 75,000 8,145,000 8,378,000 6,692,000 -2,641,000 6,560,000 2,679,000 7,136,000 8,437,000 14,004,000 16,234,000 7,554,000 7,824,000 13,056,000 7,316,000 7,229,000 1,658,000 7,569,000 7,775,000 3,704,000 8,309,000 6,781,000 7,716,000 6,195,000 4,478,000 7,231,000 8,884,000 8,815,000 7,345,000 7,059,000 6,266,000 5,800,000 11,885,000 11,763,000 11,475,000 13,547,000 7,369,000 7,285,000 7,405,000 6,439,000 6,358,000 6,299,000 
      impairment of assets
    		1,758,000 10,810,000 6,853,000   0                                          
      other
    		840,000 306,000 -16,687,000 -8,327,000 1,672,000 3,135,000 -10,619,000 -493,000 3,459,000 3,435,000 -7,101,000 132,000 10,035,000 1,225,000 3,648,000 412,000 518,000 8,821,000 214,000 122,000 201,000                           
      changes in operating assets and liabilities, net of the effects of acquisitions:
    		                                               
      accounts receivable
    		11,632,000 -6,170,000 14,188,000 -7,228,000 2,216,000 -5,535,000 1,141,000 -20,178,000 13,173,000                                       
      contract assets
    		-10,794,000 15,682,000 -3,675,000 16,116,000 -10,566,000 -1,572,000 -4,515,000 -16,340,000 -16,838,000 -9,113,000 -5,517,000 -14,602,000 -11,856,000 -8,080,000 -16,176,000 -17,087,000 -5,876,000 -7,952,000 -20,192,000 6,027,000 -29,568,000 20,704,000 -19,563,000 -578,000 -8,768,000                       
      prepaid expenses and other assets
    		-18,229,000 1,766,000 1,794,000 5,191,000 8,730,000 -5,252,000 9,956,000 -19,840,000 9,216,000                                       
      accounts payable
    		4,265,000 -148,000 757,000 -4,114,000 397,000 -6,956,000 13,065,000 5,707,000 -3,099,000                                       
      revenue share obligations
    		1,753,000 16,712,000 -2,751,000 14,435,000 26,118,000 1,030,000 11,907,000 14,023,000 3,544,000                                       
      accrued expenses, deferred revenue, and other liabilities
    		-37,989,000 7,999,000 38,195,000                                             
      net cash from operating activities from continuing operations
    		15,930,000 110,029,000 114,047,000 113,690,000 80,043,000             215,037,000 76,188,000 85,395,000 30,782,000 91,806,000 31,061,000 120,942,000 96,079,000                       
      net cash from operating activities from discontinued operations
    		-72,000 -2,044,000 82,000 -2,022,000 -12,396,000                 298,000 -690,000 -1,168,000 11,196,000                       
      net cash from operating activities
    		15,858,000 107,985,000 114,129,000 111,668,000 67,647,000 106,290,000 154,890,000 -46,496,000 81,876,000 113,365,000 134,453,000 121,974,000 74,751,000 109,445,000 137,262,000 142,340,000 55,187,000 215,037,000 76,188,000 85,395,000 30,782,000 92,104,000 30,371,000 119,774,000 107,275,000 137,203,000 155,827,000 151,982,000 60,327,000 137,972,000 163,219,000 131,482,000 75,033,000 118,036,000 135,847,000 96,537,000 41,827,000 100,533,000 132,101,000 116,117,000 22,719,000 108,483,000 101,860,000 107,842,000 45,873,000 82,253,000 90,173,000 
      capex
    		-19,504,000 -21,752,000 -21,020,000 -22,159,000 -17,718,000 -13,563,000 -18,558,000 -27,798,000 -21,270,000 -23,838,000 -20,048,000 -19,486,000 -18,930,000 -26,379,000 -18,401,000 -21,610,000 -21,050,000 -21,965,000 -22,047,000 -19,882,000 -24,982,000 -25,071,000 -24,558,000 -22,785,000 -21,983,000 -23,268,000 -22,828,000 -22,227,000 -25,062,000 -27,420,000 -26,638,000 -21,975,000 -16,647,000 -19,480,000 -17,567,000 -17,359,000 -16,966,000 -22,306,000 -15,802,000 -21,741,000 -17,141,000 0 -18,653,000 -18,051,000 -14,360,000 -15,898,000 -13,823,000 
      free cash flows
    		-3,646,000 86,233,000 93,109,000 89,509,000 49,929,000 92,727,000 136,332,000 -74,294,000 60,606,000 89,527,000 114,405,000 102,488,000 55,821,000 83,066,000 118,861,000 120,730,000 34,137,000 193,072,000 54,141,000 65,513,000 5,800,000 67,033,000 5,813,000 96,989,000 85,292,000 113,935,000 132,999,000 129,755,000 35,265,000 110,552,000 136,581,000 109,507,000 58,386,000 98,556,000 118,280,000 79,178,000 24,861,000 78,227,000 116,299,000 94,376,000 5,578,000 108,483,000 83,207,000 89,791,000 31,513,000 66,355,000 76,350,000 
      investing activities
    		                                               
      purchases of property and equipment
    		-19,504,000 -21,752,000 -21,020,000 -22,159,000 -17,718,000 -13,563,000 -18,558,000 -27,798,000 -21,270,000 -23,838,000 -20,048,000 -19,486,000 -18,930,000 -26,379,000 -18,401,000 -21,610,000 -21,050,000 -21,965,000 -22,047,000 -19,882,000 -24,982,000 -25,071,000 -24,558,000 -22,785,000 -21,983,000 -23,268,000 -22,828,000 -22,227,000 -25,062,000 -27,420,000 -26,638,000 -21,975,000 -16,647,000 -19,480,000 -17,567,000 -17,359,000 -16,966,000 -22,306,000 -15,802,000 -21,741,000 -17,141,000  -18,653,000 -18,051,000 -14,360,000 -15,898,000 -13,823,000 
      net cash from investing activities
    		-19,504,000 -61,600,000 -618,000 -22,159,000 -17,718,000 -13,563,000 -5,835,000 -27,798,000 -21,270,000 -23,838,000 -22,318,000 -207,236,000 -20,230,000 -26,379,000 -44,401,000 -21,610,000 -47,050,000 -25,277,000 -102,408,000 -21,930,000 -24,953,000 -50,368,000 -86,177,000 -57,511,000 -28,266,000 2,915,000 -25,670,000 -81,653,000 -25,062,000 -27,420,000 -26,638,000 -21,976,000 -16,646,000 -17,872,000 -110,823,000 -239,555,000 -96,803,000 1,495,000 19,642,000 5,856,000 -186,629,000 -82,716,000 -38,340,000 -50,229,000 -60,588,000 -71,671,000 -76,356,000 
      financing activities
    		                                               
      payments on notes payable
    		 -25,555,000 -25,439,000 -25,323,000 -26,214,000 -25,091,000 -24,974,000 -25,049,000 -25,823,000                                       
      proceeds from credit facility
    		120,000,000 95,000,000 240,000,000       120,000,000 65,000,000 185,000,000 100,000,000 25,000,000 125,000,000 0 175,000,000 0 100,000,000 25,000,000 100,000,000 25,000,000 250,000,000   0    0 0   0 97,500,000   0 0 0 150,000,000       
      payments on credit facility
    		-120,000,000 -70,000,000    0 0 0 -215,000,000 -140,000,000 -130,000,000   -125,000,000 0 -50,000,000 -75,000,000 -125,000,000 0 -75,000,000 -25,000,000 -200,000,000 -50,000,000 -75,000,000 -25,000,000     -100,000,000 0 0 -50,000,000 -147,500,000    -50,000,000          
      proceeds from sale of future revenues
    		 0 0 0 42,325,000 51,607,000 0 50,837,000 578,983,000                                       
      payments on liability related to the sale of future revenues
    		-10,448,000 -12,514,000 -11,165,000 -8,479,000 -20,949,000 -7,372,000 -9,552,000 -10,289,000 -4,322,000                                       
      cash dividends paid
    		-18,561,000 -17,758,000 -17,319,000 -21,045,000 -21,323,000 -22,133,000 -22,015,000 -25,232,000 -25,827,000 -25,006,000 -25,022,000 -24,987,000 -25,218,000 -23,594,000 -23,817,000 -24,192,000 -24,852,000 -23,251,000 -23,251,000 -23,201,000 -23,195,000                           
      repurchase of class a common stock
    		 1,000 -210,438,000 -133,314,000 -56,440,000 0        0 -76,213,000 -135,765,000 -38,151,000     0 -1,527,000 -117,443,000 -31,123,000 -1,293,000 -144,552,000 -91,975,000 -12,313,000 0 -129,285,000                 
      net cash from financing activities
    		-36,674,000 -34,012,000 -128,032,000 -90,549,000 -88,140,000 -29,409,000 -458,293,000 -7,883,000 302,865,000 -91,230,000 -115,266,000 3,254,000 35,976,000 -176,420,000 477,000 -218,989,000 47,143,000 -193,203,000 49,791,000 -74,868,000 15,283,000 -184,166,000 185,970,000 -75,937,000 -94,820,000 -136,575,000 -103,229,000 -102,167,000 -45,229,000 -107,576,000 -150,185,000 -78,612,000 -83,002,000 -179,647,000 -7,698,000 205,898,000 -37,829,000 -91,595,000 -70,769,000 -74,398,000 127,223,000 -34,881,000 -37,500,000 -22,519,000 -22,549,000 -30,836,000 -19,836,000 
      effect of exchange rate changes on cash flows
    		-25,000 25,000 -2,000 -66,000 21,000 -28,000 -16,000 26,000 -3,000 3,000 1,000 1,000 -10,000 -6,000 4,000                                 
      net decrease in cash and cash equivalents
    		-40,345,000                       -13,674,000 -15,811,000 3,543,000   -9,964,000    -24,615,000    -92,805,000    -36,687,000   35,094,000 -37,264,000 -20,254,000  
      cash and cash equivalents at beginning of period
    		83,725,000 0 0 0 125,146,000 0 0 0 89,793,000  0 0 86,143,000  0 0 129,141,000                      0 0 146,522,000  0 0 131,786,000   
      cash and cash equivalents at end of period
    		43,380,000 12,398,000 -14,523,000 -1,106,000 86,956,000 63,290,000 -309,254,000 -82,151,000 453,261,000 -1,700,000 -3,130,000 -82,007,000 176,630,000 -93,360,000 93,342,000 -98,260,000 184,421,000 -3,443,000 23,571,000 -11,403,000 120,416,000 -142,430,000   125,244,000  26,928,000 -31,838,000 142,422,000  -13,604,000 30,894,000 132,120,000  17,326,000    80,974,000 47,575,000 109,835,000  26,020,000 35,094,000 94,522,000   
      net income (income) from discontinued operations, net of tax
    		 137,000 771,000 39,389,000 1,604,000                                           
      equity in net (income) loss of unconsolidated affiliates
    		 -123,000 -514,000 -9,502,000 -1,833,000                                           
      proceeds from sale of assets
    		 0                    0 0 0 3,632,000                       
      acquisition of businesses, net of cash acquired
    		                 -3,311,000 -80,361,000   -25,294,000                          
      sale of investment in unconsolidated affiliates
    		     0                                          
      payments on deferred consideration related to acquisition of business
    		                                               
      payments on earn-out liabilities
    		 0                                              
      net increase in cash and cash equivalents
    		   -1,106,000 -38,190,000 63,290,000 -309,254,000 -82,151,000 363,468,000 -1,700,000 -3,130,000 -82,007,000 90,487,000 -93,360,000 93,342,000 -98,260,000 55,280,000 -3,443,000 23,571,000 -11,403,000 21,112,000             -79,483,000 17,326,000   10,433,000 80,974,000   -9,114,000      
      accrued expenses, deferred revenue and other liabilities
    		    -80,804,000 4,139,000 5,103,000 -89,668,000 124,948,000                                       
      gain on fff put and call rights
    		                 5,731,000 5,195,000    13,906,000                         
      inventory
    		     -2,004,000 -5,029,000 -2,898,000 7,064,000                              937,000 1,645,000 1,169,000       
      acquisition of businesses and equity method investments, net of cash acquired
    		         0 0   0 0 0 -26,000,000                               
      investment in unconsolidated affiliates
    		         0    0                    0 0 0 -65,660,000 0 -2,250,000         
      proceeds from exercise of stock options under equity incentive plan
    		         5,374,000 0 60,000 644,000           4,244,000 1,754,000  5,191,000 4,651,000 7,472,000  807,000 156,000 2,652,000  413,000 592,000 2,317,000  2,282,000 40,000 197,000  630,000     
      equity in net income of unconsolidated affiliates
    		         -1,521,000 -4,630,000 -1,674,000 -8,243,000 -6,340,000 -3,991,000 -6,116,000 -7,058,000 -5,050,000 -5,524,000 -4,572,000 -5,927,000 -1,499,000 -4,442,000 -2,989,000 -3,607,000 -971,000 -553,000 -1,444,000 -2,690,000 -604,000 4,939,000 -1,257,000 -4,252,000 44,000 -83,000 -5,127,000 -9,579,000 -5,645,000 -6,627,000 -4,785,000 -4,590,000 -6,473,000 -5,197,000 -4,749,000 -4,866,000 -4,805,000 -3,566,000 
      (gain) loss on fff put and call rights
    		                          4,109,000                     
      accounts receivable, inventories, prepaid expenses and other assets
    		         16,864,000 31,618,000 -6,724,000 22,495,000 33,241,000 41,254,000 27,482,000 22,682,000 113,255,000 -53,499,000 -82,295,000 -45,469,000 -25,782,000 -90,201,000 -12,724,000 6,972,000                       
      accounts payable, accrued expenses, deferred revenue, revenue share obligations and other liabilities
    		         -71,827,000 32,559,000 43,500,000 -23,822,000 -21,787,000 9,859,000   -6,052,000 51,529,000 68,025,000 20,577,000 -7,012,000 -2,894,000 3,383,000 -23,830,000                       
      payments made on notes payable
    		         -24,835,000 -24,975,000 -24,662,000 -26,387,000 -24,161,000 -24,461,000 -23,929,000 -26,692,000 -19,021,000 -28,008,000 -3,496,000 -188,000 -373,000 -1,000 -532,000 -1,513,000     -5,000 -1,139,000 -1,884,000 -4,974,000 -2,150,000 -1,998,000 -1,120,000 -218,000 -296,000 -511,000 -1,006,000 -330,000 -357,000 -362,000 -362,000 -322,000 -4,176,000 -3,195,000 
      distributions to limited partners of premier lp
    		                 0 0 0 -9,949,000 -9,314,000 -12,689,000 -13,699,000 -13,202,000 -13,079,000 -14,288,000 -14,993,000 -15,465,000 -13,157,000 -20,395,000 -20,752,000 -24,951,000 -23,071,000 -22,733,000 -22,137,000 -22,493,000 -24,742,000 -22,504,000 -23,029,000 -22,432,000 -23,412,000 -23,701,000 -22,691,000 -22,408,000 -21,299,000 -17,419,000 
      payments to limited partners of premier lp related to tax receivable agreements
    		                 0 0 0 -24,218,000 0 0 0 -17,425,000 0 0 0 -17,975,000                   
      cash and cash equivalents at beginning of year
    		                 0 0 0 99,304,000 0   141,055,000 0 0 0 152,386,000 0 0 0 156,735,000 0 0 0 248,817,000         0 0 
      income from discontinued operations, net of tax
    		                                               
      remeasurement of tax receivable agreement liabilities
    		                     0 -902,000 -28,356,000 4,674,000     0 0                 
      (gain) loss on fff call/put rights
    		              0 0 -64,110,000                               
      proceeds from exercise of stock options
    		              118,000                                 
      accounts payable, accrued expenses, deferred revenue, revenue share obligations and other current liabilities
    		                -70,014,000                               
      (income) income from discontinued operations, net of tax
    		                     -45,000 -5,000 -614,000 -390,000                       
      impairment of held to maturity investments
    		                     0                          
      net cash from investing activities from continuing operations
    		                     -50,368,000 -86,177,000                         
      net cash from investing activities from discontinued operations
    		                                               
      investments in unconsolidated affiliates
    		                     0 0 -5,500,000 -4,665,000                       
      loss on fff put and call rights
    		                    1,919,000    7,839,000    3,283,000 3,362,000 3,067,000                 
      earn-out liability payment to gnyha holdings
    		                             0 0                 
      other operating activities
    		                      -893,000 409,000 2,562,000 243,000 2,021,000 116,000 382,000 -322,000 19,000 184,000 6,422,000 7,352,000 -4,526,000 550,000 -387,000 1,588,000 -829,000 843,000 -535,000 690,000 670,000 555,000 596,000 2,046,000 -320,000 
      other investing activities
    		                      0 5,501,000 -5,250,000 24,000       1,000 0 -1,000 21,000 5,000 74,000 -96,000 -439,000 434,000  -796,000 -128,000 481,000   
      other financing activities
    		                                       193,000 -174,000       
      changes in operating assets and liabilities:
    		                                               
      acquisition of stanson health, inc., net of cash acquired
    		                         0 72,000                     
      acquisition of medpricer.com, inc., net of cash acquired
    		                                               
      redemption of limited partner of premier lp
    		                         0 512,000                     
      proceeds from issuance of class a common stock under employee stock purchase plan
    		                                               
      repurchase of vested restricted units for employee tax-withholding
    		                       -47,000 -8,311,000 -12,000 -92,000 -1,082,000 -6,948,000 -49,000 -173,000 -14,000 -5,729,000 -39,000 -49,000 -194,000 -17,435,000           
      remeasurement gain attributable to acquisition of innovatix, llc
    		                                  0             
      loss on disposal of long-lived assets
    		                         6,378,000    651,000 5,000 400,000 1,320,000 179,000 725,000 0 1,518,000           
      accounts receivable, prepaid expenses and other current assets
    		                             -10,733,000 -3,091,000 8,281,000 -8,748,000 -3,672,000 18,925,000 -3,769,000 -8,119,000 -10,179,000 -826,000 -6,106,000 -20,139,000 4,681,000 -12,369,000 6,314,000 -17,590,000 -1,052,000 -426,000 
      inventories
    		                         239,000 5,257,000 -1,796,000 -2,097,000 -8,909,000 4,837,000 -4,463,000 -7,178,000 -1,656,000 17,139,000 -31,005,000 -827,000      -2,181,000 -5,197,000 -1,657,000 -1,543,000 -3,164,000 
      other assets
    		                         -4,358,000 -4,528,000 5,117,000 -2,235,000 -1,202,000 -682,000 -319,000 1,379,000 6,416,000 131,000 1,386,000 -1,112,000 135,000 1,080,000 1,433,000 -12,286,000 -606,000 2,624,000 -3,882,000 128,000 69,000 2,000 
      accounts payable, deferred revenue and other current liabilities
    		                                               
      accrued expenses
    		                                               
      long-term liabilities
    		                         2,166,000 4,810,000 -7,019,000 -14,000 5,337,000 49,000 1,398,000 -111,000 320,000 2,879,000 -4,422,000 322,000 -2,949,000 -1,412,000 447,000 -281,000 374,000 1,743,000 1,699,000 -1,025,000 -3,577,000 313,000 
      acquisition of innovatix, llc and essensa ventures, llc, net of cash acquired
    		                                  -97,500,000             
      acquisition of acro pharmaceuticals, net of cash acquired
    		                                               
      investments in convertible notes
    		                         0 -3,000,000                     
      cancellation of convertible note
    		                                               
      proceeds from sale of marketable securities
    		                                 0 0 0 48,013,000 18,772,000 27,926,000 31,940,000 307,734,000 87,031,000 108,023,000 52,074,000 138,660,000 76,560,000 33,770,000 
      distributions received on equity investments in unconsolidated affiliates
    		                                               
      premier, inc.
    		                                               
      consolidated statements of cash flows
    		                                               
      proceeds from exercise of stock options under equity incentive plans
    		                                               
      proceeds from issuance of class a common stock under stock purchase plan
    		                             1,231,000 0   1,227,000 0   1,015,000 0         
      settlement of exchange of class b units by member owners
    		                                 -1,000 -23,331,000             
      cash and cash equivalents at end of year
    		                                    156,012,000         -20,254,000 -6,019,000 
      supplemental schedule of non cash investing and financing activities:
    		                                               
      increase in redeemable limited partners' capital for adjustment to fair value, with offsetting decrease (increase) in additional paid-in-capital and accumulated deficit
    		                                               
      reduction in redeemable limited partners' capital, with offsetting increase in common stock and additional paid-in capital related to quarterly exchange by member owners
    		                                        -3,268,000       
      reduction in redeemable limited partners' capital for limited partners' distribution payable
    		                                  112,811,000      23,028,000    22,691,000 999,000 3,933,000 
      distributions utilized to reduce subscriptions, notes, interest and accounts receivable from member owners
    		                                 488,000 487,000      1,613,000    3,112,000 27,000 14,000 
      net increase in deferred tax assets related to quarterly exchanges by member owners and other adjustments
    		                                 20,011,000              
      net increase in tax receivable agreement liabilities related to quarterly exchanges by member owners and other adjustments
    		                                               
      net increase in additional paid-in capital related to quarterly exchanges by member owners and other adjustments
    		                                               
      net increase in investments in unconsolidated affiliates related to deferred taxes attributed to the net fair value of fff enterprises, inc. put and call rights, with offsetting increases in deferred tax assets and deferred tax liabilities
    		                                               
      payable to member owners incurred upon repurchase of ownership interest
    		                                 284,000       373,000    1,515,000 129,000 0 
      accounts receivable, contract assets, prepaid expenses and other current assets
    		                          -11,000 -15,448,000 -41,427,000                   
      accounts payable, accrued expenses, deferred revenue and other current liabilities
    		                          22,507,000 37,142,000 -21,776,000                   
      accounts payable, accrued expenses and other current liabilities
    		                             23,077,000 29,928,000 1,695,000 -21,933,000 -13,400,000 -6,946,000 34,327,000 -38,463,000           
      purchase of marketable securities
    		                                     0 0 0 -19,211,000 -155,520,000 -116,246,000 -89,124,000 -34,412,000 -131,713,000 -138,001,000 
      acquisition of cecity.com, inc., net of cash acquired
    		                                     0 0 0 -398,261,000       
      acquisition of healthcare insights, llc, net of cash acquired
    		                                     0 360,000 0 -64,634,000       
      acquisition of inflowhealth, llc
    		                                     0          
      final remittance of net income attributable to former s2s global minority shareholder
    		                                     0          
      adjustment to tax receivable agreement liability
    		                                  2,768,000 0 -5,722,000 0 0 0 -4,818,000   0 1,073,000   
      loss on investment
    		                                               
      adjustment to tax receivable agreement liabilities
    		                                               
      remeasurement gain attributable to acquisition of innovatix
    		                                               
      acquisition of innovatix and essensa, net of cash acquired
    		                                               
      acquisition of cecity, net of cash acquired
    		                                               
      acquisition of hci, net of cash acquired
    		                                               
      acquisition of inflow
    		                                               
      acquisition of aperek, net of cash acquired
    		                                          0 0 -47,446,000   
      acquisition of theradoc, net of cash acquired
    		                                          0 0 -108,561,000   
      purchase of non-controlling interest in s2s global
    		                                               
      distributions received on equity investment
    		                                   0 6,550,000 5,050,000 5,300,000 6,293,000 5,450,000 5,000,000 3,850,000 5,000,000 5,050,000 5,000,000 3,850,000 
      decrease in restricted cash
    		                                               
      proceeds from s2s global revolving line of credit
    		                                         0 207,000 600,000 200,000   
      payments on s2s global revolving line of credit
    		                                         0 -14,215,000     
      reduction in redeemable limited partners' capital for limited partners' capital distribution payable
    		                                               
      increase in additional paid-in capital related to quarterly exchanges by member owners
    		                                               
      net increase in investments in unconsolidated affiliates related to fff put and call rights, with offsetting increases in other assets and other liabilities
    		                                               
      acquisition of acro pharmaceutical services llc and community pharmacy services, llc, net of cash acquired
    		                                  4,245,000 0 -68,745,000           
      acquisition of inflow health, llc
    		                                               
      decrease in redeemable limited partners' capital for adjustment to fair value, with offsetting decreases in additional paid-in-capital and accumulated deficit
    		                                               
      reduction in redeemable limited partners' capital, with offsetting increases in common stock and additional paid-in capital related to quarterly exchanges by member owners
    		                                               
      net increase in tax receivable agreement liability related to quarterly exchanges by member owners and other adjustments
    		                                               
      net increase in investments in unconsolidated affiliates related to fff enterprises, inc. put and call rights, with offsetting increases in other assets and other liabilities
    		                                               
      decrease in redeemable limited partners' capital for adjustment to fair value, with offsetting decrease in additional paid-in-capital and accumulated deficit
    		                                               
      reduction in redeemable limited partners' capital, with offsetting increase in common stock and additional paid-in capital related to quarterly exchanges by member owners
    		                                               
      increase in deferred tax assets related to quarterly exchanges by member owners
    		                                               
      increase in tax receivable agreement liability related to quarterly exchanges by member owners
    		                                               
      reduction in deferred tax assets related to departed member owners
    		                                        312,000       
      reduction in tax receivable agreement liability related to departed member owners
    		                                        789,000       
      gain on investment
    		                                         0      
      proceeds from sale of investment in ghx
    		                                               
      acquisition of aperek, inc., net of cash acquired
    		                                               
      acquisition of theradoc, inc., net of cash acquired
    		                                               
      acquisition of symmedrx, net of cash acquired
    		                                             0 -2,000 
      acquisition of meddius, l.l.c, net of owner note receivable
    		                                               
      acquisition of memdata, llc, net of cash acquired
    		                                               
      payments made in connection with the origination of the credit facility
    		                                               
      proceeds from issuance of class a common stock in connection with the ipo, net of underwriting fees and commissions
    		                                               
      payments made in connection with the ipo
    		                                               
      purchases of class b common units from member owners
    		                                             0 0 
      proceeds from issuance of pshi common stock
    		                                               
      proceeds from notes receivable from partners
    		                                             -21,000 -20,000 
      issuance of limited partnership interest for notes receivable
    		                                             0 0 
      reduction in redeemable limited partners' capital to reduce outstanding receivable
    		                                             0 0 
      distributions and notes payable utilized to reduce subscriptions, notes, interest and accounts receivable from member owners
    		                                               
      increase in redeemable limited partners' capital for adjustment to redemption amount, with offsetting decrease in additional paid-in capital and accumulated deficit
    		                                               
      increase in additional paid-in capital related to quarterly exchanges by member owners and departure of member owners
    		                                               
      increase in deferred tax assets related to purchase of non-controlling interest in s2s global
    		                                               
      increase in deferred tax assets and additional paid-in capital related to the reorganization
    		                                               
      increase in payables and decrease in additional paid-in capital pursuant to the tax receivable agreements
    		                                               
      reduction in prepaid expenses and other current assets for ipo costs capitalized to additional paid-in capital
    		                                               
      accounts payable, accrued expenses, revenue share obligations and other current liabilities
    		                                      33,826,000 20,334,000 -32,710,000 25,164,000 24,424,000 28,978,000 -17,732,000 -5,268,000  
      purchase of noncontrolling interest in s2s global
    		                                         0      
      proceeds from sale of property and equipment
    		                                               
      repurchase of restricted units
    		                                      -17,000 -8,000 -38,000 -45,000 -59,000 -12,000 -19,000 -7,000 -2,000 
      employee stock purchase plan expense
    		                                               
      payments on senior secured line of credit
    		                                             0 0 
      final remittance of net income attributable to s2s global before february 1, 2015
    		                                               
      investment in unconsolidated affiliate
    		                                        -1,000,000       
      supplemental schedule of non-cash investing and financing activities:
    		                                               
      increase in redeemable limited partners' capital for adjustment to redemption amount, with offsetting increase in additional paid-in-capital and accumulated deficit
    		                                        -466,801,000       
      increase in additional paid-in capital related to quarterly exchange by member owners and departure of member owners
    		                                        879,000       
      increase in tax receivable agreement liability related to quarterly exchange by member owners
    		                                        1,013,000       
      increase in deferred tax assets related to quarterly exchange by member owners
    		                                        1,415,000       
      proceeds from sale of investment in global healthcare exchange, llc
    		                                             522,000  
      acquisition of meddius, l.l.c., net of owner note receivable
    		                                             0 0 
      capital expenditures
    		                                               
      proceeds from senior secured line of credit
    		                                             0 0 
      payments made in connection with the origination of credit facility
    		                                               
      proceeds from issuance of phsi common stock
    		                                             0 0 
      proceeds from issuance of redeemable limited partnership interest
    		                                               
      deferred taxes
    		                                          -1,186,000 -3,492,000 4,409,000 6,987,000 240,000 
      increase in redeemable limited partners' capital for adjustment to redemption amount, with offsetting decrease in additional paid-in-capital and accumulated deficit
    		                                            382,657,000   
      reduction in prepaid expenses and other current assets for ipo costs capitalized to additional paid-in-capital
    		                                              154,000 
      gain on sale of investment
    		                                             -522,000  
      increase in redeemable limited partners' capital for adjustment to redemption amount, with offsetting decrease in additional paid-in-capital and retained earnings
    		                                             -461,161,000 -517,063,000 
      proceeds from svs, llc revolving line of credit
    		                                              800,000 
      proceeds from issuance of class a common stock in connection with the ipo, net of expenses
    		                                              0 
      increase in deferred tax assets and additional paid-in-capital related to the reorganization
    		                                              0 
      increase in payables and decrease in additional paid-in-capital pursuant to the tax receivable agreement
    		                                              0 
      issuance of common stock for subscriptions receivable
    		                                               
      
    		                                               
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.